ArticleThe Lancet. Oncology2013
2-weekly versus 3-weekly docetaxel for prostate cancer.
David M Nanus et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleThe Lancet. Oncology2013
David M Nanus et al.PubMed ↗Publisher ↗
No numbers read from the abstract.